Apixaban in a Morbid Obese Patient with Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation

We present the case of a 45-year-old man with atrial fibrillation and morbid obesity (weight 128 kg, height 168 cm, BMI 45.4) who was switched from Warfarin 5 mg once daily to Apixaban 5 mg twice daily because he did not achieve at least 60% of the time in therapeutic range. We performed serial dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Vincenzo, Paccone, Andrea, Rago, Anna, Maddaloni, Valeria, Iafusco, Dario, Proietti, Riccardo, Atripaldi, Umberto, D’Onofrio, Antonio, Golino, Paolo, Nigro, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061727/
https://www.ncbi.nlm.nih.gov/pubmed/32184692
http://dx.doi.org/10.2147/JBM.S229526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061727/
https://www.ncbi.nlm.nih.gov/pubmed/32184692
http://dx.doi.org/10.2147/JBM.S229526

Ejemplares similares